Loading
Latest filing published 10 Jul 2025 for JW (Cayman) Therapeutics Co. Ltd - B.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Li Yiping James appears in our data through filings on JW (Cayman) Therapeutics Co. Ltd - B shares, published by HKEX. Between 8 February 2021 and 7 July 2025, the trades on record add up to 10 filings.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 10 July 2025 came the latest disclosure, a transaction in JW (Cayman) Therapeutics Co. Ltd - B. The latest purchase dates back some time: it was published 1,839 days ago, on 12 October 2021. Filings reach the HKEX feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations